BioXcel Therapeutics - 48 Year Dividend History | BTAI

Historical dividend payout and yield for BioXcel Therapeutics (BTAI) since 1971. The current TTM dividend payout for BioXcel Therapeutics (BTAI) as of September 18, 2019 is $0.00. The current dividend yield for BioXcel Therapeutics as of September 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.166B $0.000B
BioXcel Therapeutics Inc. is a clinical stage biopharmaceutical company. It focuses on drug development which utilizes novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology. The company's product portfolio include BXCL501, a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. BioXcel Therapeutics Inc. is based in the United States.
Stock Name Country Market Cap PE Ratio